ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1490	National Cancer Institute	Html	en	Hypopharyngeal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of hypopharyngeal cancer.	statistically significant survival 0.552817 pharynx cancer incidence 0.54678 hypopharyngeal SCCs 0.568302 United States 0.594562 Multiple primary tumors 0.590618 hypopharyngeal wall tumors 0.623965 neck squamous cell 0.598149 PUBMED Abstract 0.631322 pharyngeal cancer 0.54424 5-year disease-free survival 0.561931 Otolaryngol Head Neck 0.607335 squamous cell 0.712263 hypopharyngeal carcinomas 0.629276 neck cancer patients 0.603767 Cancer Res 0.688393 squamous cell cancer 0.573486 hypopharyngeal tumor 0.566864 Abstract 0.707746 pyriform sinus 0.633965 functional larynx 0.541602 patients 0.659221 Hypopharyngeal carcinoma 0.566532 induction chemotherapy arm 0.707576 hypopharyngeal squamous cell 0.623336	squamous cell carcinomas 0.681165 hypopharyngeal SCC 0.56973 upper alimentary tract 0.554127 Natl Cancer Inst 0.619483 pyriform sinus cancer 0.551602 immediate surgery arm 0.623979 neoadjuvant chemotherapy 0.990124 field cancerization 0.600816 hypopharyngeal cancer. 0.653244 significant survival advantage 0.54752 neck cancer 0.685166 Clin Cancer Res 0.614389 radiation therapy 0.868288 Head Neck Surg 0.701435 hypopharyngeal cancers 0.604268 squamous carcinoma 0.542607 induction chemotherapy 0.745083 posterior pharyngeal wall 0.598262 hypopharyngeal cancer 0.866148 prospective randomized trial 0.63031 retrospective study 0.58561 squamous cell carcinoma 0.669554 standard adjuvant therapy 0.638264	CLICK HERE
1670	National Cancer Institute	Html	en	Oral Cavity and Oropharyngeal Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for oral cancer.	cancer treatment 0.462069 cancer screening methods 0.510918 ongoing clinical trials 0.459171 following PDQ summaries 0.498704 PDQ cancer information 0.601619 squamous cells 0.461192 Oropharyngeal cancer forms 0.542461 clinical trials 0.552349 test result 0.478895 cancer information summary 0.545028 clinical trial 0.464502 breast cancer prevention 0.475292 fluorescent mouth rinse 0.459409 PDQ Oral Cavity 0.538179 cancer patients 0.455495 latest published information 0.461223 Oropharyngeal Cancer Prevention 0.539186 NCI’s PDQ 0.469112 cancer symptoms 0.470328 NCI PDQ cancer 0.519444 tests 0.472016 certain types 0.45905 Oral cavity cancer 0.562303 PDQ Screening 0.487794	treatment 0.479473 abnormal tissue 0.496498 screening tests 0.460194 oropharyngeal cancers 0.542436 Cancer Information Service 0.4864 Prevention Editorial Board 0.494212 treatment clinical trials 0.460544 National Cancer Institute 0.552754 PDQ documents 0.4638 new treatment 0.461424 Cancer screening trials 0.51442 oropharyngeal cancer screening 0.581362 Cancer Care page 0.477739 PDQ database 0.466412 PDQ summary 0.507494 cells 0.483262 abnormal red patch 0.460863 abnormal white patch 0.460254 cancer information summaries 0.491365 oral cavity 0.970425 comprehensive cancer information 0.49122 cancer 0.792804 oropharyngeal cancer 0.758721 early stage 0.462272	CLICK HERE
1817	National Cancer Institute	Html	es	Tratamiento del neuroblastoma (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del neuroblastoma.	proteína mycn 0.336322 International Neuroblastoma 0.628182 International Neuroblastoma Risk 0.447509 Internacional Neuroblastoma Staging 0.44498 Sin embargo 0.822701 Internacional Neuroblastoma 0.565858 neuroblastoma chd5 0.470002 largo plazo 0.351143 presuntos tumores 0.343323 Risk Group Project 0.315769 high-risk neuroblastoma 0.457856 anomalía cromosómica 0.341006 proteínas myc 0.40081 receptor tipo 0.334046 Group Staging System 0.316719 siguientes genes 0.322225 Macmillan Publishers Ltd 0.319163 cinasa alk 0.340921 Neuroblastoma Pathology Classification 0.578931 presumible neuroblastoma 0.448924 adultos jóvenes 0.346234 Children’s Oncology Group 0.362343 gen alk 0.512613 siguientes tipos 0.316031 estadio 4 0.468918	alargamiento alternativo 0.316851 riesgo intermedio 0.515053 efectos tardíos 0.336486 PDQ Efectos tardíos 0.326203 escasa expresión 0.31757 ensayo clínico alemán 0.317939 Risk Group 0.325182 supuesto gen 0.321026 ploidy or mycm 0.321186 tumores hiperdiploides 0.348329 gen tert 0.322687 PDQ Tratamiento 0.315838 características histológicas 0.911452 International Neuroblastoma Pathology 0.574297 site or frameshit 0.320313 pronóstico adverso 0.322402 asimismo mutaciones 0.347925 cromosómicas segmentarias versus 0.354412 sección mutaciones 0.348351 mutaciones activadoras 0.395132 Internacional Neuroblastoma Group 0.477285 Staging System 0.328084 anticuerpo anti-GD2 0.335718 mecanismos genéticos aberrantes 0.321444	CLICK HERE
1825	National Cancer Institute	Html	es	Tratamiento del cáncer de hígado infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento cáncer de hígado infantil.	liver tumors 0.936797 Pediatric Oncology 0.824708 PRETEXT III 0.10879 Aronson DC 0.0851201 results from 0.266716 Paediatric Oncology 0.0823629 international pediatric liver 0.110029 Tumor Study Group 0.204309 standard-risk hepatoblastoma 0.125193 childhood liver tumors 0.0905382 Study Group 0.298822 Maibach R 0.0922692 hepatocellular carcinoma 0.861587 International Society 0.42048 IV hepatoblastoma 0.218263 Krailo MD 0.0915991 cog liver tumors 0.124853 Children's Oncology Group 0.248758 Estados Unidos 0.091099 hepatoblastoma with 0.740659 pediatric liver tumors 0.222622 hepatoblastoma after chemotherapy 0.124744 Pediatric Oncology Liver 0.123326 childhood hepatoblastoma 0.552956 with hepatoblastoma 0.638805	Perilongo G 0.171974 PRETEXT IV 0.0802866 grupos pretext 0.174753 Group intergroup study 0.0861929 Pediatr Blood Cancer 0.319797 Oncology Group study 0.119848 childhood liver 0.102417 Japanese Study Group 0.0968813 report from 0.211803 Childrens Cancer Study 0.0958008 quimioterapia preoperatoria 0.196007 Hepatoblastoma presenting with 0.134427 Liver Tumor Study 0.217304 Pediatr Surg 0.270609 Clin Oncol 0.979661 Hepatoblastoma metastatic 0.11507 Otte JB 0.0939222 Children's Cancer Group 0.202883 Shafford E 0.259892 prospective study 0.154606 Oncology Liver Tumor 0.132492 pediatric oncology group 0.588258 oncology group 0.803949 Cancer Study Group 0.108904	CLICK HERE
1911	National Cancer Institute	Html	es	Tratamiento del cáncer de células renales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de células renales.	siguientes procedimientos 0.302667 mal uso 0.302989 siguientes aspectos 0.301319 estadio ii 0.309628 túbulos renales 0.304796 pequeños trozos 0.300679 siguientes tipos 0.302146 Renal Cell 0.303601 rayos x 0.302568 sistema urinario masculino 0.3018 enlace drugs approved 0.306606 riñón sano donado 0.303031 National Cancer Institute 0.300453 siguientes riesgos 0.300391 realidad células 0.303887	pelvis renal 0.306725 Instituto Nacional 0.301826 PDQ Tratamiento 0.304405 Physician Data Query 0.301827 nefrectomía radical 0.310748 pequeña incisión 0.300747 tumor mide 0.303146 von hippel-lindau 0.30106 vejiga almacena 0.301249 pequeños túbulos 0.301281 siguientes enlaces 0.300545 células renales 0.988263 riesgo cáncer 0.31289 siguientes pruebas 0.301322 vasos sanguíneos 0.317262	CLICK HERE
1994	National Cancer Institute	Html	es	Tratamiento del craneofaringioma infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del craneofaringioma infantil	childhood-onset craniopharyngioma 0.555421 Winkfield KM 0.461372 Merchant TE 0.538632 Pediatric Patients with 0.460492 largo plazo 0.456579 brain tumors 0.465364 cystic craniopharyngiomas 0.546839 pediatric craniopharyngiomas with 0.478389 after childhood-onset craniopharyngioma 0.509117 calcificación quizás 0.453393 craneofaringioma infantil grupo 0.448145 past treatment modalities 0.44452 Instituto Nacional 0.469284 Proton beam therapy 0.44785 proton radiotherapy 0.445521 Radiat Oncol Biol 0.691179 Pediatric Brain Tumor 0.463199 Endocrinol Metab 0.525086 Gebhardt U 0.460882 central nervous system 0.452583 proton therapy 0.48171 tumor control 0.4621 Optimal treatment strategy 0.445937 radiation therapy 0.847388 Clin Endocrinol Metab 0.477641	following treatment 0.481728 subtotal quizás 0.449448 Neurosurg Focus 0.603105 Pediatric MATCH 0.494065 pediatric craniopharyngioma 0.961568 tumores quísticos recidivantes 0.450542 PDQ Descripción 0.449293 Pediatr Blood Cancer 0.611837 after radiation therapy 0.60095 With Craniopharyngioma That 0.51489 efectos tardíos 0.785518 PDQ Efectos tardíos 0.471103 tumor control with 0.459757 Neurosurgical treatment 0.478026 National Cancer Institute 0.453747 with proton radiotherapy 0.445448 tumor quizás 0.486067 PDQ Tratamiento 0.463786 treatment strategy 0.478645 long-term results 0.483149 Oncol Biol Phys 0.703438 Neurosurg Pediatr 0.66815 long-term gh therapy 0.447185 patients with craniopharyngioma 0.738686	CLICK HERE
3900	National Cancer Institute	Html	en	Public Health Service Act	Information on the Public Health Service Act and related legislation that directly impacted the mission of NCI.	future NIH reorganizations 0.419512 Human Services 0.393504 Biomedical Research Panel 0.846998 biomedical research program 0.579792 American merchant seamen 0.370969 national research institutes 0.416708 recent Administration record 0.353386 NIH reporting requirements 0.42538 National Institutes 0.458558 President’s Cancer 0.359747 cancer patients 0.397757 scientific peer review 0.364817 class cancer care 0.399826 Reduced minimum number 0.342577 National Cancer Program. 0.421335 new Comprehensive Cancer 0.408225 NCI 0.391469 National Cancer Act 0.681476 Scientific Management Review 0.343953 National Cancer Program 0.508981 Cancer Panel meetings 0.406859 President’s Biomedical 0.473241 occupation carcinogenesis research 0.398948 NIH resources 0.361136 International Cancer Research 0.440008	national cancer 0.744834 intensified research program 0.423987 basic research laboratory 0.420967 cancer communication activities 0.401446 information dissemination programs 0.354532 Rep. Joe Barton 0.339975 committee 0.46056 national cancer control 0.4441 Committee Report No. 0.405931 Medical Facilities Construction 0.355248 NCI Director 0.348101 NIH research activities 0.511683 NIH director 0.411073 NIH 0.520603 new authorizing language 0.385653 cancer centers 0.388024 Health Service Act 0.762452 cancer control mandate 0.391408 program coordination 0.359566 Public Health Service 0.988569 research contracts 0.341664 research programs 0.355014 control activities research 0.408316 exfoliative cytology tests 0.366574	CLICK HERE
4337	National Cancer Institute	Html	en	Appetite Loss and Cancer Treatment	Cancer treatments may lower your appetite. Side effects such as nausea, fatigue, or mouth sores can also making eating difficult. Learn how to eat well to avoid losing weight or becoming dehydrated, so you stay strong during treatment.	Care PDQ® summary 0.905921 questions 0.493671 liquids 0.644562 dietitian 0.466542 short walk 0.691875 health care team 0.956003 professional version 0.683094 variety 0.451735 causes 0.450224 nurse 0.455725 Prepare 0.451462 dehydration 0.472596 throat problems 0.73358 drink choices 0.682925 vomiting 0.475861 food tastes 0.745638 Cancer treatments 0.729931 cancer patients 0.671489 supplemental nutrition drinks 0.886258 weight 0.457616 large meals 0.701392 plenty 0.541422	calories 0.468062 list 0.493655 eating 0.456684 steps 0.457353 people 0.451814 dangerous condition 0.706738 small meals 0.702125 way 0.460708 nausea 0.479468 nutritional problems 0.667746 doctor 0.457447 symptoms 0.451468 supplements 0.451833 Cancer-related fatigue 0.794241 effects 0.460377 mouth 0.464482 vitamins 0.459091 NCI 0.456663 high-nutrient foods 0.702331 appetite 0.964964 information 0.45027 nutrient-dense foods 0.715035	CLICK HERE
4338	National Cancer Institute	Html	en	Memory or Concentration Problems and Cancer Treatment	Cancer treatments, such as chemo, may cause difficulty thinking, concentrating, or other cognitive problems. Learn about steps people with cancer can take to manage these side effects. See a list of helpful questions for families to ask the doctor.	cognitive problems 0.80867 cancer treatment 0.62932 phone numbers 0.602305 occupational therapists 0.593535 questions 0.471687 family member 0.916079 type 0.442055 greater memory 0.624849 chemotherapy 0.446122 health care team 0.805887 poor nutrition 0.618951 electronic device 0.597541 things 0.6294 small changes 0.62165 social worker 0.598295 daily planner 0.596862 biological therapies 0.636385 mental exercises 0.597838 important information 0.613471 night 0.47682 chemo brain 0.652554 list 0.545178 steps 0.478481 symptoms 0.475521 radiation therapy 0.635339	minor memory 0.611151 bit more difficulty 0.644087 additional support 0.600444 short naps 0.667478 mental fog 0.64322 light physical exercises 0.781082 health-related factors 0.640365 Mind–body practices 0.607504 vocational therapists 0.597413 Exercise releases endorphins 0.792537 concentration problems 0.963343 Long naps 0.655178 feel-good chemicals 0.628223 daily routine 0.619747 types 0.441521 Cancer treatments 0.637599 cognitive changes 0.602139 important activities 0.605353 neuropsychologists 0.454252 people 0.518089 doctor 0.475116 help 0.443453 important names 0.60441 extra rest 0.613564	CLICK HERE
16600	National Cancer Institute	Html	en	Aspirin to Reduce Cancer Risk	A federal advisory panel supports aspirin to reduce the risk of colorectal cancer, while researchers are investigating whether it may help reduce the risk of other cancers.	high-dose daily aspirin 0.674804 colorectal cancer prevention 0.571738 USPSTF chair Kirsten 0.487385 long-term aspirin 0.663026 Dr. Umar 0.469811 University Comprehensive Cancer 0.508256 recent Harvard study 0.46976 colorectal cancer risk 0.79898 task force 0.503648 Harvard Medical School 0.473077 clinical trials 0.598455 colorectal cancer screening 0.565807 observational studies 0.495177 long-running cohort studies 0.481808 Cancer Center 0.506614 reduced risk 0.481524 colorectal cancer 0.931694 ovarian cancer 0.471756 Nature Reviews Cancer 0.518208 aspirin group 0.617639 low-dose aspirin 0.665023 gastrointestinal cancer 0.48385 Dr. Hawk 0.575018 federal advisory panel 0.47098 randomized clinical trials 0.478512	colorectal cancers 0.549284 Dr. Brasky 0.505177 cancer type 0.471148 U.S. Preventive Services 0.472306 heart attack 0.471676 longer-term aspirin 0.60828 cancer prevention 0.597763 United States 0.478678 aspirin’s inhibition 0.619167 interval cancer rate 0.501859 pancreatic cancer 0.472024 Cancers Research Group 0.481416 aspirin 0.98518 studies 0.539154 different aspirin doses 0.642633 cardiovascular disease 0.514113 MD Anderson Cancer 0.5105 Dana-Farber Cancer Institute—using 0.498216 regular aspirin 0.76763 people 0.473586 lump aspirin 0.623949 average colorectal cancer 0.575376 JAMA Oncology 0.46922 cancers—participants given aspirin 0.673562	CLICK HERE